Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity

S Zang, KA Ponto, GJ Kahaly - The Journal of Clinical …, 2011 - academic.oup.com
abstract Context: The administration of iv glucocorticoid pulses has been advocated as a
treatment approach for patients with inflammatory and moderate to severe Graves' …

[HTML][HTML] Thyroid-associated ophthalmopathy

E Şahlı, K Gündüz - Turkish journal of ophthalmology, 2017 - ncbi.nlm.nih.gov
Thyroid-associated ophthalmopathy is the most frequent extrathyroidal involvement of
Graves' disease but it sometimes occurs in euthyroid or hypothyroid patients. Thyroid …

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO

L Bartalena, L Baldeschi, A Dickinson… - European Journal of …, 2008 - academic.oup.com
Methods European Group on GO (EUGOGO) represents a multidisciplinary consortium of
clinicians from the European centers, who share a commitment to improving the …

Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy

L Bartalena, L Baldeschi, AJ Dickinson, A Eckstein… - Thyroid, 2008 - liebertpub.com
Graves' orbitopathy (GO) constitutes a major clinical and therapeutic challenge (1, 2). GO is
an autoimmune disorder representing the commonest and most important extrathyroidal …

Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis

H Stiebel-Kalish, E Robenshtok… - The Journal of …, 2009 - academic.oup.com
Background: Graves' ophthalmopathy (GO) is a common cause of morbidity in patients with
Graves' disease. Optimal treatment of GO remains unclear, and an evidence-based …

The evaluation and treatment of graves ophthalmopathy

MN Stan, JA Garrity, RS Bahn - Medical Clinics, 2012 - medical.theclinics.com
Graves ophthalmopathy (GO) is an inflammatory disorder of the orbit that occurs in
association with autoimmune thyroid disease. 1 Although most patients with GO have a …

Thyroid associated orbitopathy

R Maheshwari, E Weis - Indian Journal of Ophthalmology, 2012 - journals.lww.com
Thyroid associated orbitopathy, also known as Graves' orbitopathy, is typically a self-limiting
autoimmune process associated with dysthyroid states. The clinical presentation may vary …

A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans

BS Berthon, LK MacDonald-Wicks, LG Wood - Nutrition Research, 2014 - Elsevier
Obesity is a serious risk factor for chronic disease, and commonly prescribed oral
glucocorticoids (OCS) may be contributing to the prevalence of obesity. The objective of this …

Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association

C Marcocci, T Watt, MA Altea… - European Journal of …, 2012 - academic.oup.com
Objective The objective of this study was to investigate the side effects of glucocorticoid (GC)
therapy observed by European thyroidologists during the treatment of Graves' orbitopathy …

Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy

C Marcocci, M Marinò - Best practice & research clinical endocrinology & …, 2012 - Elsevier
Treatment of Graves' orbitopathy (GO) is better performed through a multidisciplinary
approach. Euthyroidism should be promptly restored. Antithyroid drug and thyroidectomy are …